Press Releases about Moderna Inc
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna to Present at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference
January 04, 2022
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://mms.businesswire.com/media/20211220005253/en/839474/5/KO_LOGO.jpg)
Moderna Announces Preliminary Booster Data and Updates Strategy to Address Omicron Variant
December 20, 2021
From Moderna, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211213006004/en/839474/5/KO_LOGO.jpg)
Moderna and Australia Announce Collaboration to Bring mRNA Manufacturing to Australia
December 13, 2021
From Moderna, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211210005268/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211210005215/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211209006075/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211209005634/en/839474/5/KO_LOGO.jpg)
From Moderna, Inc.
Via Business Wire
Biotech Sector’s Response to Omicron Panic Should be Swift and Effective
December 07, 2021
Exposures
COVID-19
![](https://mms.businesswire.com/media/20211201006260/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211122006214/en/839474/5/KO_LOGO.jpg)
Moderna to Present at Upcoming Investor Conferences in December 2021
November 22, 2021
From Moderna, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211119005733/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211119005436/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211118005257/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211117005889/en/839474/5/KO_LOGO.jpg)
Moderna Tops BioSpace’s 2022 Best Places to Work Ranking in Large Employer Category
November 17, 2021
From Moderna, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211117005865/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211116005778/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211115005887/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211115005816/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211112005897/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211109006033/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211104005580/en/839474/5/KO_LOGO.jpg)
Global COVID-19 Therapeutics Market Size Now Expected To Exceed $25 Billion In 2030
November 09, 2021
Topics
Death
![](https://mms.businesswire.com/media/20211102005512/en/839474/5/KO_LOGO.jpg)
![](https://mms.businesswire.com/media/20211101005330/en/839474/5/KO_LOGO.jpg)
From Moderna, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211031005022/en/839474/5/KO_LOGO.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.